Difference between revisions of "2011 EHR Quality Measure Spec 81"
Peterbodtke (talk | contribs) |
(Added a glossary link to Action~) |
||
(One intermediate revision by one other user not shown) | |||
Line 20: | Line 20: | ||
'''PDF FILE URL''' | '''PDF FILE URL''' | ||
− | + | https://docs.google.com/fileview?id=1wJF8NoT6nhVwy82LWxlNa2E_goT6focCGuzA_YXox45kfKMnLsVWYDwgGZIe&hl=en | |
'''REGARDING MULTIPLE NUMERATORS''' | '''REGARDING MULTIPLE NUMERATORS''' | ||
Line 50: | Line 50: | ||
'''DEVELOPMENT STATUS''' (Add details here) | '''DEVELOPMENT STATUS''' (Add details here) | ||
− | '''ACTION ITEMS / NEXT STEPS''' (Add details here) | + | '''[[ACTION~|Action]] ITEMS / NEXT STEPS''' (Add details here) |
'''PREPARE CERTIFICATION DOCUMENTATION''' (Add details here) | '''PREPARE CERTIFICATION DOCUMENTATION''' (Add details here) | ||
'''OPEN ISSUES / QUESTIONS''' (Add details here) | '''OPEN ISSUES / QUESTIONS''' (Add details here) |
Latest revision as of 21:29, 29 July 2012
MEASURE # 81
MEASURE TITLE Heart Failure (HF) : Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
MEASURE DESCRIPTION Percentage of patients aged 18 years and older with a diagnosis of heart failure and LVSD (LVEF < 40%) who were prescribed ACE inhibitor or ARB therapy.
Documents for 2011 EHR-Based Reporting
SPREADSHEET NQF_Retooled_Measure_0081.xlsx
SPREADSHEET GOOGLE DOC URL (editable) http://spreadsheets.google.com/a/worldvista.org/ccc?key=0ArxIkIV4NePEdG5YQ3ZzZDFsQ0xkaTFIc2VZUWFMT1E&hl=en&authkey=CJWn_NsJ
PDF FILE NAME NQF_HQMF_HumanReadable_0081.pdf
PDF FILE URL https://docs.google.com/fileview?id=1wJF8NoT6nhVwy82LWxlNa2E_goT6focCGuzA_YXox45kfKMnLsVWYDwgGZIe&hl=en
REGARDING MULTIPLE NUMERATORS N/A
TARGET DATE | SOLUTION DEVELOPERS | STATUS | SPEC DEVELOPER | NUMERATOR(s) | DENOMINATOR(s) |
---|---|---|---|---|---|
1-Nov-10 | TBD | N/A | AMA | 1 | 1 |
SOLUTION DESIGN / TECHNOLOGY (Add details here)
SOLUTION COMPONENTS (Add details here)
DEPENDENCIES (Add details here)
COMMENTS / NOTES (Add details here)
DEVELOPMENT STATUS (Add details here)
Action ITEMS / NEXT STEPS (Add details here)
PREPARE CERTIFICATION DOCUMENTATION (Add details here)
OPEN ISSUES / QUESTIONS (Add details here)